Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements

v3.2.0.727
Fair Value Measurements
6 Months Ended
Jun. 30, 2015
Fair Value Disclosures [Abstract]  
Fair Value Measurements

4. Fair Value Measurements

The following fair value hierarchy table presents information about the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2015 and December 31, 2014:

 

     Fair Value Measurement as of June 30, 2015  
     Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
     Significant
Other Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
 

Cash equivalents

   $ 23,372,289       $ —        $ —    

Marketable securities

     11,621,731         —          —    

Warrant liability

     —          —          521,400   
  

 

 

    

 

 

    

 

 

 

Total

   $ 34,994,020       $ —        $ 521,400   
  

 

 

    

 

 

    

 

 

 

 

     Fair Value Measurement as of December 31, 2014  
     Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
     Significant
Other Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
 

Cash equivalents

   $ 25,628,918       $ —        $ —    

Marketable securities

     1,670,606         —          —    

Warrant liability

     —          —          313,004   
  

 

 

    

 

 

    

 

 

 

Total

   $ 27,299,524       $ —        $ 313,004   
  

 

 

    

 

 

    

 

 

 

 

The Company issued a warrant to the underwriter of its IPO, classified it as a liability and considers it as a Level 3 financial instrument (see also Note 8, “Capital Structure”). The warrant will be re-measured at each subsequent reporting period and changes in fair value will be recognized in the statement of operations. The following assumptions were used in a Black-Scholes option-pricing model to determine the fair value of the warrant liability:

 

     As of
June 30, 2015
    As of
December 31, 2014
 

Expected volatility

     74.0     74.8

Remaining contractual term (in years)

     4.17        4.67   

Risk-free interest rate

     1.32     1.65

Expected dividend yield

     —       —  

The following tables present a reconciliation of the Company’s financial liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three and six months ended June 30, 2015 and 2014:

Warrant liabilities (1)

 

     Three Months Ended
June 30,
     Six Months Ended
June 30,
 
     2015      2014      2015      2014  

Balance at beginning of period

   $ 525,059       $ 4,263,124       $ 313,004       $ 3,088,017   

Issuances of convertible notes

     —          611,376         —          865,635   

Increase (decrease) in fair value (2)

     (3,659      774,748         208,396         1,695,596   
  

 

 

    

 

 

    

 

 

    

 

 

 

Balance at end of period

   $ 521,400       $ 5,649,248       $ 521,400       $ 5,649,248   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

Embedded derivatives liabilities (1)

 

           
     Three Months Ended
June 30,
     Six Months Ended
June 30,
 
     2015      2014      2015      2014  

Balance at beginning of period

   $ —        $ 1,944,103       $ —        $ 2,680,780   

Issuances of convertible notes

     —          278,805         —          537,607   

Decrease in fair value (2)

     —          (76,166      —          (1,071,645
  

 

 

    

 

 

    

 

 

    

 

 

 

Balance at end of period

   $ —        $ 2,146,742       $ —        $ 2,146,742   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) Prior to the closing of the Company’s IPO on August 1, 2014, the Company considered its convertible note related warrant liabilities and embedded derivatives liabilities as Level 3 financial instruments. The Company determined the fair value of these liabilities immediately prior to the Company’s IPO and then reclassified the balances to additional paid-in capital on the closing of the IPO.
(2) The change in the fair values of the warrant and embedded derivatives liabilities are recorded in other expenses in the statement of operations.